Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
Glioblastoma heterogeneity in circulating tumour DNA

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.07.16
Views: 2285
Rating:

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Dr Seoane speaks with ecancertv at EACR 2016 about his research into glioblastoma using circulating tumour DNA.

He assesses the value of ctDNA for tracking patient disease and response, with less invasive procedures and valuable sequencing data available.

For more on ctDNA, you can read ecancer coverage here or watch interviews from this year's ASCO conference with Dr Oliver Zill and Prof Philip Mack.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation